Literature DB >> 11590166

The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway.

Y H Lin1, H F Yang-Yen.   

Abstract

We have recently demonstrated that the gene encoding the osteopontin (OPN) protein is activated both by interleukin-3 and granulocyte-macrophage colony-stimulating factor signaling pathways and that, through binding to the cell surface receptor CD44, OPN contributes to the survival activities of interleukin (IL)-3 and GM-CSF (Lin, Y.-H., Huang, C.-J., Chao, J.-R., Chen, S.-T., Lee, S.-F., Yen, J. J.-Y., and Yang-Yen, H.-F. (2000) Mol. Cell. Biol. 20, 2734-2742). In this report, we demonstrate that the CD44-binding domain of OPN involves a region containing amino acid residues from 121 to 140 and that both threonine and serine at positions 137 and 147, respectively, are essential for the survival stimulatory effect of OPN. Substitution of either residue with alanine results into a dominant negative mutant that overrides the survival effect of IL-3. Upon binding to the CD44 receptor, the wild-type OPN but not the inactive mutant induces activation of phosphatidylinositol 3-kinase and Akt. Last, we demonstrate that two waves of Akt activation are detected in IL-3-treated cells and that the survival promoting effect of OPN is mediated predominantly through the phosphatidylinositol 3-kinase/Akt signaling pathway. Together, our results suggest that a positive autoregulatory loop is involved in the survival pathway of IL-3.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590166     DOI: 10.1074/jbc.M105132200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  81 in total

1.  An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion.

Authors:  John D Klement; Amy V Paschall; Priscilla S Redd; Mohammed L Ibrahim; Chunwan Lu; Dafeng Yang; Esteban Celis; Scott I Abrams; Keiko Ozato; Kebin Liu
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

2.  Tumor-derived osteopontin isoforms cooperate with TRP53 and CCL2 to promote lung metastasis.

Authors:  Ioanna Giopanou; Ioannis Lilis; Vassilios Papaleonidopoulos; Theodora Agalioti; Nikolaos I Kanellakis; Nikolitsa Spiropoulou; Magda Spella; Georgios T Stathopoulos
Journal:  Oncoimmunology       Date:  2016-11-18       Impact factor: 8.110

3.  Studies on the role of osteopontin-1 in endometrial cancer cell lines.

Authors:  J C Hahne; S R Meyer; P Kranke; J Dietl; M Guckenberger; B Polat; A Hönig
Journal:  Strahlenther Onkol       Date:  2013-10-16       Impact factor: 3.621

4.  Prognostic value of the expression of phosphatase and tensin homolog and CD44 in elderly patients with refractory acute myeloid leukemia.

Authors:  Xiao Huang; Dongyun Li; Tiantian Li; B O Zhao; Xinyi Chen
Journal:  Oncol Lett       Date:  2015-05-06       Impact factor: 2.967

5.  Multifaceted regulation of T cells by CD44.

Authors:  Bas Jg Baaten; Cheng-Rui Li; Linda M Bradley
Journal:  Commun Integr Biol       Date:  2010-11-01

6.  Elevated osteopontin expression and proliferative/apoptotic ratio in the colorectal adenoma-dysplasia-carcinoma sequence.

Authors:  Gábor Valcz; Ferenc Sipos; Tibor Krenács; Jeannette Molnár; Arpád V Patai; Katalin Leiszter; Kinga Tóth; Norbert Solymosi; Orsolya Galamb; Béla Molnár; Zsolt Tulassay
Journal:  Pathol Oncol Res       Date:  2010-03-27       Impact factor: 3.201

Review 7.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

8.  Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders.

Authors:  Gurudutt Pendyala; Howard S Fox
Journal:  Genome Med       Date:  2010-03-30       Impact factor: 11.117

9.  The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways.

Authors:  Donald Courter; Hongbin Cao; Shirley Kwok; Christina Kong; Alice Banh; Peiwen Kuo; Donna M Bouley; Carmen Vice; Odd Terje Brustugun; Nicholas C Denko; Albert C Koong; Amato Giaccia; Quynh-Thu Le
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

10.  Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tumorigenesis in K-ras (LA1) mice.

Authors:  Arash Minai-Tehrani; Seung-Hee Chang; Jung-Taek Kwon; Soon-Kyung Hwang; Ji-Eun Kim; Ji-Young Shin; Kyeong-Nam Yu; Sung-Jin Park; Hu-Lin Jiang; Ji-Hye Kim; Seong-Ho Hong; Bitna Kang; Duyeoul Kim; Chan-Hee Chae; Kee-Ho Lee; George R Beck; Myung-Haing Cho
Journal:  Cell Oncol (Dordr)       Date:  2012-10-16       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.